Bankrupt DNA testing firm 23andMe to be purchased for $256m

theguardian.com/technology/2025/may/19/23andme-to-be-purchased-256m

Drugmaker Regeneron Pharmaceuticals will buy the genetic testing firm through a bankruptcy auction
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256m through a bankruptcy auction, the companies said on Monday.
Regeneron said it will comply with…

This story appeared on theguardian.com, 2025-05-19 14:24:28.
The Entire Business World on a Single Page. Free to Use →